Literature DB >> 26975704

Age- and Hypertension-Associated Protein Aggregates in Mouse Heart Have Similar Proteomic Profiles.

Srinivas Ayyadevara1, Federico Mercanti2, Xianwei Wang2, Samuel G Mackintosh2, Alan J Tackett2, Sastry V S Prayaga2, Francesco Romeo2, Robert J Shmookler Reis1, Jawahar L Mehta1.   

Abstract

Neurodegenerative diseases are largely defined by protein aggregates in affected tissues. Aggregates contain some shared components as well as proteins thought to be specific for each disease. Aggregation has not previously been reported in the normal, aging heart or the hypertensive heart. Detergent-insoluble protein aggregates were isolated from mouse heart and characterized on 2-dimensional gels. Their levels increased markedly and significantly with aging and after sustained angiotensin II-induced hypertension. Of the aggregate components identified by high-resolution proteomics, half changed in abundance with age (392/787) or with sustained hypertension (459/824), whereas 30% (273/901) changed concordantly in both, each P<0.05. One fifth of these proteins were previously associated with age-progressive neurodegenerative or cardiovascular diseases, or both (eg, ApoE, ApoJ, ApoAIV, clusterin, complement C3, and others involved in stress-response and protein-homeostasis pathways). Because fibrosis is a characteristic of both aged and hypertensive hearts, we posited that aging of fibroblasts may contribute to the aggregates observed in cardiac tissue. Indeed, as cardiac myofibroblasts "senesced" (approached their replicative limit) in vitro, they accrued aggregates with many of the same constituent proteins observed in vivo during natural aging or sustained hypertension. In summary, we have shown for the first time that compact (detergent-insoluble) protein aggregates accumulate during natural aging, chronic hypertension, and in vitro myofibroblast senescence, sharing many common proteins. Thus, aggregates that arise from disparate causes (aging, hypertension, and replicative senescence) may have common underlying mechanisms of accrual.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  aging (cardiac); cardiovascular diseases; hypertension; neurodegenerative diseases; protein aggregates

Mesh:

Substances:

Year:  2016        PMID: 26975704      PMCID: PMC4833546          DOI: 10.1161/HYPERTENSIONAHA.115.06849

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  55 in total

Review 1.  Cardiovascular physiology-changes with aging.

Authors:  Melvin D Cheitlin
Journal:  Am J Geriatr Cardiol       Date:  2003 Jan-Feb

2.  Vascular injury induces expression of periostin: implications for vascular cell differentiation and migration.

Authors:  Volkhard Lindner; Qiaozeng Wang; Barbara A Conley; Robert E Friesel; Calvin P H Vary
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-10-28       Impact factor: 8.311

3.  Clarifying the cardiac proteasome paradox: protein quality control.

Authors:  Christopher C Glembotski
Journal:  Circ Res       Date:  2012-08-17       Impact factor: 17.367

4.  C-reactive protein and the risk of developing hypertension.

Authors:  Howard D Sesso; Julie E Buring; Nader Rifai; Gavin J Blake; J Michael Gaziano; Paul M Ridker
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

Review 5.  Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease.

Authors:  Victoria Cachofeiro; Marian Goicochea; Soledad García de Vinuesa; Pilar Oubiña; Vicente Lahera; José Luño
Journal:  Kidney Int Suppl       Date:  2008-12       Impact factor: 10.545

6.  Apolipoprotein(a) genetic polymorphism and serum lipoprotein(a) concentration in patients with peripheral vascular disease.

Authors:  J Pedro-Botet; M Sentí; T Auguet; X Nogués; J Rubiés-Prat; C Aubó; F Vidal-Barraquer
Journal:  Atherosclerosis       Date:  1993-12       Impact factor: 5.162

7.  Neurodegeneration--from multiple sclerosis to Alzheimer's disease.

Authors:  Wolfgang Meyerhof; Dietmar Richter
Journal:  FEBS J       Date:  2013-07-29       Impact factor: 5.542

Review 8.  Protein misfolding and neurodegeneration.

Authors:  Claudio Soto; Lisbell D Estrada
Journal:  Arch Neurol       Date:  2008-02

9.  Complement component C3 and risk of age-related macular degeneration.

Authors:  Dominiek D G Despriet; Cornelia M van Duijn; Ben A Oostra; Andre G Uitterlinden; Albert Hofman; Alan F Wright; Jacoline B ten Brink; Arne Bakker; Paulus T V M de Jong; Johannes R Vingerling; Arthur A B Bergen; Caroline C W Klaver
Journal:  Ophthalmology       Date:  2009-01-24       Impact factor: 12.079

Review 10.  Caenorhabditis elegans as a model system for studying non-cell-autonomous mechanisms in protein-misfolding diseases.

Authors:  Carmen I Nussbaum-Krammer; Richard I Morimoto
Journal:  Dis Model Mech       Date:  2014-01       Impact factor: 5.758

View more
  34 in total

1.  Loss-of-function mutations in co-chaperone BAG3 destabilize small HSPs and cause cardiomyopathy.

Authors:  Xi Fang; Julius Bogomolovas; Tongbin Wu; Wei Zhang; Canzhao Liu; Jennifer Veevers; Matthew J Stroud; Zhiyuan Zhang; Xiaolong Ma; Yongxin Mu; Dieu-Hung Lao; Nancy D Dalton; Yusu Gu; Celine Wang; Michael Wang; Yan Liang; Stephan Lange; Kunfu Ouyang; Kirk L Peterson; Sylvia M Evans; Ju Chen
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

Review 2.  Proteostasis in cardiac health and disease.

Authors:  Robert H Henning; Bianca J J M Brundel
Journal:  Nat Rev Cardiol       Date:  2017-06-29       Impact factor: 32.419

3.  Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans.

Authors:  Nicole Groh; Ivan Gallotta; Marie C Lechler; Chaolie Huang; Raimund Jung; Della C David
Journal:  J Vis Exp       Date:  2017-11-26       Impact factor: 1.355

Review 4.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

5.  Reconstitution of autophagy ameliorates vascular function and arterial stiffening in spontaneously hypertensive rats.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Fabiano B Calmasini; Nicole S Klee; Michael W Brands; Bina Joe; R Clinton Webb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-30       Impact factor: 4.733

6.  Novel Contributors and Mechanisms of Cellular Senescence in Hypertension-Associated Premature Vascular Aging.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; R Clinton Webb; Bina Joe
Journal:  Am J Hypertens       Date:  2019-07-17       Impact factor: 2.689

Review 7.  The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety.

Authors:  Hania K Flaten; Andrew A Monte
Journal:  Cardiovasc Drugs Ther       Date:  2017-08       Impact factor: 3.727

8.  Angiotensin II- and Alzheimer-Type Cardiovascular Aging.

Authors:  Hannah A Cooper; Rosario Scalia; Victor Rizzo; Satoru Eguchi
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

Review 9.  Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology.

Authors:  Satoru Eguchi; Tatsuo Kawai; Rosario Scalia; Victor Rizzo
Journal:  Hypertension       Date:  2018-03-26       Impact factor: 10.190

Review 10.  Vascular Stress Signaling in Hypertension.

Authors:  Stephanie M Cicalese; Josiane Fernandes da Silva; Fernanda Priviero; R Clinton Webb; Satoru Eguchi; Rita C Tostes
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.